Concentrics Research
Go
RX-to-OTC
Switch
Healthcare
Market
Research
Clinical
Research
Our
Research
Facility
About Us
Divisions
Services
Contact Us
Tag Archives:
FDA
Concentrics Research conducts pivotal studies for novel FDA OTC Naloxone labeling – work cited as unprecedented by FDA Commissioner
Posted January 18th, 2019. Filed under
Concentrics News
Tags:
FDA
,
Naloxone
,
Pivotal Study
https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm629571.htm
News & Events
Categories
Concentrics News
Web design
by BoxCrush®
7ads6x98y